Iris S H Kloots

5PUBLICATIONS
34CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|May 28, 2026
EMETPRO: a multicentric, international, retrospective analysis evaluating patients with metastatic hormone-sensitive prostate cancer with early progression.

|Nov 01, 2025
Molecular reflex testing in patients with early metastatic castration-resistant prostate cancer within the PROMPT-study.

Iris S H Kloots, Peter H J Slootbeek, Sofie H Tolmeijer

|Jun 22, 2023
Cross-Resistance between Platinum-Based Chemotherapy and PARP Inhibitors in Castration-Resistant Prostate Cancer.

Peter H J Slootbeek, Iris S H Kloots, Inge M van Oort

|May 27, 2023
Transcriptome Profiling of Circulating Tumor Cells to Predict Clinical Outcomes in Metastatic Castration-Resistant Prostate Cancer.

Levi Groen, Iris Kloots, David Englert

|Jan 20, 2022
Responsiveness to Immune Checkpoint Inhibitors Is Associated With a Peripheral Blood T-Cell Signature in Metastatic Castration-Resistant Prostate Cancer.

Donjete Simnica, Minke Smits, Edith Willscher

Pageof 1

Frequent Collaborators

5 joint publications

Niven Mehra

3 joint publications

Peter H J Slootbeek

2 joint publications

Leonie I Kroeze

1 joint publications

David Englert